RMTI (Rockwell Medical) Total Liabilities : $27.95 Mil (As of Sep. 2024)

View and export this data going back to 1998. Start your Free Trial

What is Rockwell Medical Total Liabilities?

Rockwell Medical's Total Liabilities for the quarter that ended in Sep. 2024 was $27.95 Mil.

Rockwell Medical's quarterly Total Liabilities declined from Mar. 2024 ($30.08 Mil) to Jun. 2024 ($29.53 Mil) and declined from Jun. 2024 ($29.53 Mil) to Sep. 2024 ($27.95 Mil).

Rockwell Medical's annual Total Liabilities declined from Dec. 2021 ($46.04 Mil) to Dec. 2022 ($32.53 Mil) and declined from Dec. 2022 ($32.53 Mil) to Dec. 2023 ($30.88 Mil).

Rockwell Medical Total Liabilities Historical Data

The historical data trend for Rockwell Medical's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rockwell Medical Total Liabilities Chart

Rockwell Medical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

24.00

43.58

46.04

32.53

30.88

Rockwell Medical Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Liabilities	Get a 7-Day Free Trial															31.09	30.88	30.08	29.53	27.95

Rockwell Medical Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Rockwell Medical's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	16.637	+	(11.256	+	0.014000000000001
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	2.975	+	0)
	=	30.88

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	52.173	-	21.291
	=	30.88

Rockwell Medical's Total Liabilities for the quarter that ended in Sep. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	14.178	+	(11.566	+	0.014
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	2.191	+	0)
	=	27.95

Total Liabilities	=	Total Assets (Q: Sep. 2024 )	-	Total Equity (Q: Sep. 2024 )
	=	57.084	-	29.135
	=	27.95

Rockwell Medical Total Liabilities Related Terms

Thank you for viewing the detailed overview of Rockwell Medical's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Rockwell Medical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Rockwell Medical Inc (NAS:RMTI) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

RWMA:Germany RWMA:Germany

Address

30142 S. Wixom Road, Wixom, MI, USA, 48393

Website

https://www.rockwellmed.com

Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others.

Executives

Mark H Ravich	other: See Footnote 1
Mark Strobeck	director, officer: President and CEO	460 EAST SWEDESFORD ROAD, SUITE 1050, WAYNE PA 19087
Jesse Neri	officer: SVP, FINANCE	851 DUPORTAIL ROAD, SECOND FLOOR, CHESTERBROOK PA 19087
Joan Lau	director	C/O RENOVACOR, INC., 5 MEAD POINT DRIVE, GREENWICH CT 06830
Russell Skibsted	officer: See Remarks	15 TRANQUILITY PLACE, LADERA RANCH CA 92694
Megan C. Timmins	officer: SVP, General Counsel	600 LEE ROAD, SUITE 100, WAYNE PA 19087
Allen Nissenson	director	601 HAWAII ST., EL SEGUNDO CA 90245
Robert S Radie	director	101 LINDENWOOD DRIVE, SUITE 225, MALVERN PA 19355
Andrea Heslin Smiley	director	600 LEE ROAD, SUITE 100, WAYNE PA 19087
David S. Richmond	10 percent owner, other: See Footnote 1	3568 WILDWOOD AVENUE, JACKSON MI 49202
Russell H Ellison	director	270 RIVERSIDE DR., APT. 12D, NEW YORK NY 10025
Marc L Hoffman	officer: Chief Medical Officer	30142 WIXOM ROAD, WIXOM MI 48393
John Peter Mclaughlin	director	C/O PDL BIOPHARMA, INC., 932 SOUTHWOOD BOULEVARD, INCLINE VILLAGE NV 89451
Richmond Brothers, Inc.	10 percent owner, other: See Footnote 1	7415 FOXWORTH COURT, JACKSON MI 49201
Stuart M Paul	director, officer: Chief Executive Officer	HOME DIAGNOSTICS, INC., 2400 NW 55TH COURT, FORT LAUDERDALE FL 33309